Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia 2020-12-02 08:09
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S. 2020-12-01 21:45
ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy 2020-12-01 21:00
Kaltech's Disinfectant Deodorizer Proved to Have Infectivity Suppression Effect against Novel Coronavirus (COVID-19) Floating in Fixed Space 2020-12-01 14:05
Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments 2020-12-01 00:00
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19 2020-11-30 10:45
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology 2020-11-30 08:09
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing 2020-11-27 21:00
Sedana Medical submits market approval application for the drug Sedaconda 2020-11-27 20:35
Nanoform launches technology for biologics and sets new near-term business target for 2021 2020-11-27 14:04
Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis 2020-11-27 08:39
Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia 2020-11-26 21:35
Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevity 2020-11-26 16:00
Gustaf Salford appointed Elekta CEO by Board of Directors 2020-11-26 14:59
RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA 2020-11-25 16:06
MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients 2020-11-25 08:00
RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences 2020-11-25 07:00
Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2020-11-25 06:00
China Biologic Reports Financial Results for the Third Quarter of 2020 2020-11-25 05:30
1 268 269 270 271 272 451